Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Pharmacy chains sue Bausch Health, other drugmakers for overcharging for diabetes drug

Published 2019-12-03, 06:34 a/m
Updated 2019-12-03, 07:08 a/m
Pharmacy chains sue Bausch Health, other drugmakers for overcharging for diabetes drug

Dec 3 (Reuters) - Three pharmacy chains, including Walgreens Boots Alliance WBA.O , have filed a lawsuit against drugmakers Bausch Health Inc BHC.TO , Assertio Therapeutics ASRT.O and Lupin Ltd LUPN.NS , seeking damages for overcharging for Bausch's diabetes drug Glumetza.

The lawsuit, filed on Monday, alleges that Assertio and Lupin struck a deal with units of Bausch to delay the entry of their generic versions of Glumetza and allowed the companies to "maintain a monopoly" in the sale of the branded drug and its generic copies.

Bausch, Assertio and Lupin did not immediately respond to Reuters' request for comment.

Albertson Companies Inc ABS.N and Kroger (NYSE:KR) Inc KR.N were among the other defendants.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.